References
- Alayash A.I., D'Agnillo F., Buehler P.W. First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives. Expert Opin. Biol. Ther. 2007; 7(5)665–675
- Bannister J. V., Bannister W. H. Isolation and characterization of superoxide dismutase. Methods in Enzymology 1984; 105: 88–93
- Beauchamp C., Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels 1. Anal. Biochem. 1971; 44: 276–287
- Chang T.M.S. Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Common. 1971; 44(6)1531–1536
- Chang, T.M.S. (1997). Blood Substitutes: Principles, Methods, Products and Clinical Trials. Vol. 1, McGill University, Montreal ( full text and updates available for free online viewing at, , www.artcell.mcgill.ca).
- Chang T.M.S. Monograph on ARTIFICIAL CELLS: Biotechnology, Nanotechnology, Blood Substitutes, Regenerative Medicine, Bioencapsulation, Cell/Stem Cell Therapy. World Science Publisher, Singapore 2007
- Chang T.M.S. Nanobiotechnological modification of hemoglobin and enzymes from this laboratory. Biochimica et Biophysica Acta: Proteins & Proteomics 2008; 1784: 1435–144
- Chang, T.M.S. 2009. Nanobiotechnology for hemoglobin based blood substitutes. Critical Care Clinics, (in press).
- D'Agnillo F., Chang T.M.S. PolyHb-superoxide dismutase. catalase as a blood substitute with antioxidant properties. Nature Biotechnology 1998; 16(7)667–671
- Fossati P., Prencipe L., Berti G. Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clinical Chemistry 1980; 26: 227–231
- Giulivi C., Davies K. J. A. A novel antioxidant role for hemoglobin: the comproportionation of ferrylhemoglobin with oxyhemoglobin. J. Biol. Chem 1990; 265: 19453–19460
- Gould S. A., et al. The life-sustaining capacity of human polymerized Hb when red cells might be unavailable. J. Am. Coll. Surg. 2002; 195: 445–452
- Moore E.E., et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 2009; 208: 1–13
- Pearce, L.B., Gawryl, M.S., Rentko, V.T., Moon-Massat, P.F. and Rausch, C.W. (2006). HBOC-201 (Hb Glutamer-250 (Bovine), hemopure): clinical studies. In. Winslow, R.. Blood Substitutes, Academic Press, San Diego, pp. 437–4509.